GCNJ9: A Role in Modulating Sleep and Neural Activity (G3765)

Target Name: KCNJ9

NCBI ID: G3765

KCNJ9

GCNJ9: A Role in Modulating Sleep and Neural Activity

G protein-activated inward rectifier potassium channels (GRICs) are a family of ion channels that play a crucial role in the regulation of neural signaling. They are found in nearly all types of neurons and are involved in the generation and propagation of action potentials, which are the fundamental signals that carry information from the cell to the next.

KCNJ9 is a well-known GRIC that is expressed in many different types of neurons, including cardiac, skeletal, and sensory neurons. It is involved in the regulation of action potentials and has been implicated in a number of neurological and psychiatric disorders.

One of the key functions of GCNJ9 is its role in modulating the rapid resting potential (REM) that occurs during sleep. During REM sleep, the brain is active and the body is in a state of paralysis, and GCNJ9 is thought to play a key role in regulating the rapid eye movements (REMs) that are characteristic of this stage of sleep.

In addition to its role in modulating REM sleep, GCNJ9 is also involved in the regulation of other types of neural activity, including action potentials in neurons and the regulation of ion channels in neuron cell membranes. It is thought to play a key role in the regulation of the resting membrane potential of neurons and has been shown to play a role in the development of certain neurological conditions, such as epilepsy.

Due to its involvement in a number of important cellular processes, GCNJ9 is of interest as a potential drug target. Researchers are currently working to develop compounds that can selectively modulate GCNJ9 activity and may have therapeutic applications in a variety of neurological and psychiatric disorders.

In addition to its potential clinical applications, GCNJ9 is also of interest as a potential biomarker for certain neurological disorders. The regulation of GCNJ9 activity has been implicated in a number of neurological disorders, including epilepsy, and changes in GCNJ9 activity have been observed in the brains of individuals with certain psychiatric disorders.

Overall, GCNJ9 is a complex and important channel that plays a crucial role in the regulation of neural activity. Its potential as a drug target and biomarker make it an attractive target for further research and may lead to new treatments for a variety of neurological and psychiatric disorders.

Protein Name: Potassium Inwardly Rectifying Channel Subfamily J Member 9

Functions: This receptor is controlled by G proteins. Inward rectifier potassium channels are characterized by a greater tendency to allow potassium to flow into the cell rather than out of it. Their voltage dependence is regulated by the concentration of extracellular potassium; as external potassium is raised, the voltage range of the channel opening shifts to more positive voltages. The inward rectification is mainly due to the blockage of outward current by internal magnesium (By similarity)

The "KCNJ9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KCNJ9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets